Drug Company

May 21, 2015 at 22:43 | Source:
Kabra Drugs' board meeting will be held on May 30, 2015, to consider the take on record of Audited Financial Result of the Company for the Quarter and Financial Year ended on March 31, 2015 and to release the Audited Result to Press.
May 21, 2015 at 16:10 | Source:
Ishita Drugs & Industries has informed that a meeting of the Board of Directors of the Company will be held on May 29, 2015, to consider and approve the Audited Financial Results of the company for the year ended March 31, 2015.
May 21, 2015 at 15:42 | Source:
Beryl Drugs Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 30, 2015, to consider and approve the Audited Financial Result of the Company for the year ended March 31, 2015.
May 21, 2015 at 12:32 | Source: PTI
Lennox-Gastaut syndrome is a form of childhood-onset epilepsy. "Glenmark has been granted tentative approval last week by the United States Food and Drug Administration (USFDA) for its Rufinamide tablets," the company said in a BSE filing.
May 18, 2015 at 12:40 | Source: CNBC-TV18
Dinesh Dua, chief executive officer, Nectar Life Sciences, expects the companys margin to be close to 20 percent.
May 15, 2015 at 15:19 | Source: PTI
Consolidated total income of the company rose to Rs 2,288.23 crore for the fourth quarter of 2014-15 from Rs 1,968.50 crore for the same period a year ago.
May 13, 2015 at 20:47 | Source: PTI
The company has acquired 100 percent equity stake in Medquimica Industria Farmaceutica subject to certain closing conditions, Lupin said in a statement without disclosing the financial details.
May 13, 2015 at 12:38 | Source: PTI
Neurodegenerative diseases include Alzheimer's, Schizophrenia and Parkinson's. In a BSE filing, the company said it has been granted "one product patent from Europe and one product patent from Hong Kong corresponding to the new chemical entities for the treatment of disorders associated with neurodegenerative diseases".
May 13, 2015 at 08:21 | Source: PTI
Sun Pharma Advanced Research Company was demerged from Sun Pharma as a pharma research and drug discovery company in 2007. Shares of SPARC closed at Rs 379.50 per scrip on the BSE, down 4.05 per cent from the previous close.
May 13, 2015 at 00:16 | Source:
Trimurthi Drugs & Pharmaceuticals board meeting will be held on May 27, 2015, to transact the following items of business thereat to review the performance of the company. Consider, approve and take on record the Audited financial results for the year ended and quarter ended March 31, 2015.
Messages on Drug Company »


Gold Member


Dr Reddys Labs  

The US market continues to drive growth for Dr Reddy`s and other Indian generic drug companies. What if this paradigm changes in the global context? The US drives the growth but we have to diversify our sources of growth even though the relative importance of the US may not change. Emerging markets

8.53 PM Jun 30th 2014

anil patil

Platinum Member


Aurobindo Pharm  

deal details with the stock exchanges showed. Morgan Stanley Asia Singapore, which is a shareholder of Aurobindo Pharma, sold 17,32,500 shares of the drug company for about Rs 670 apiece, valuing the transaction at Rs 116 crore. Morgan Stanley Asia Singapore held 46.16 lakh shares of Aurobindo Pharma

11.48 AM May 31st 2014


Platinum Member


Dishman Pharma  

Dishman Pharma is likely to move to UC after 28.05.2014. This drug company will find support at Rs.125/- on account of excellent results. Your best time to pick up this stock at the bottom fishing zone.

8.43 PM May 26th 2014


New Member



Drug Policy Control Order (DPCO) put a cap on the prices of 348 essential drugs, is likely to impact domestic revenue generation of both homegrown and multinational drug companies in 2014

12.55 PM May 15th 2014


Platinum Member



, according to data tracker Dealogic. Many drug companies have paid down debt taken on during a buying spree in the earlier 2000s and are now generating lots of cash they want to put to work. Prescription drug makers are also attracted to acquisitions because deals can allow them cut costs and scale back

4.02 PM Apr 22nd 2014


New Member


Aurobindo Pharm buy , rather accumulate Auro even at current levels for a 1-2 year timeframe. these US legalities are nothing new to Indian drug companies,happens all the time !

10.06 AM Apr 17th 2014

Web Messenger

Platinum Member


Sun Pharma  

Source:VC Circle - Sun Pharmaceutical Industries Ltd, the country's top drugmaker by market cap, is acquiring Ranbaxy Laboratories Ltd in an all-stock transaction, creating the world's fifth-largest generics drug company and the largest pharma company in India by far

12.10 PM Apr 8th 2014


Platinum Member


Sun Pharma  

Is it patent dispute with Drug company UCB?

9.16 PM Mar 18th 2014


Gold Member


Vivimed Labs  

I am doctor by profession and knows the value of research and upcoming drugs. COMPANY has spent lot of rs in research and next quarter filing new ADNA / molecules which will drive the earning. you see almost 90% of shares are by institutes or large investor.

12.47 PM Mar 18th 2014

Web Messenger

Platinum Member



Source:Calcutta Telegraph News - Mumbai, Feb. 20: Cipla has entered into an agreement with MSD to market the latter’s anti-HIV drug raltegravir in the country. This is the first time that Cipla is entering into a strategic partnership with a multinational drug company. MSD is the trade name

2.10 PM Feb 21st 2014

News across the web »
Explore Moneycontrol

Copyright © Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of is prohibited.